Značka DEMONSTRate: Drug Evalutation in Melanoma: ONcology STudy and Research of Ipilimumab, založená v 2010 (United States), z 496 sesterských značek a 17478 konkurenčních značek. DEMONSTRate: Drug Evalutation in Melanoma: ONcology STudy and Research of Ipilimumab je značkou BRISTOL-MYERS SQUIBB COMPANY, kótované na burze v New York. DEMONSTRate: Drug Evalutation in Melanoma: ONcology STudy and Research of Ipilimumab patří do odvětví Výrobci léků činnosti.

DEMONSTRate: Drug Evalutation in Melanoma: ONcology STudy and Research of Ipilimumab je značkou BRISTOL-MYERS SQUIBB COMPANY (BMY). Novinky

Cena akcií BRISTOL-MYERS SQUIBB COMPANY (DEMONSTRate: Drug Evalutation in Melanoma: ONcology STudy and Research of Ipilimumab)

Cena akcií
Oblíbenost DEMONSTRate: Drug Evalutation in Melanoma: ONcology STudy and Research of Ipilimumab (BRISTOL-MYERS SQUIBB COMPANY)

Popularita
Udržitelnost BRISTOL-MYERS SQUIBB COMPANY

Udržitelnost
Ostatní značky BRISTOL-MYERS SQUIBB COMPANY

Ostatní značky
Konkurenční značky DEMONSTRate: Drug Evalutation in Melanoma: ONcology STudy and Research of Ipilimumab

Konkurenční značky
Novinky

Novinky

Všechny novinky
BRISTOL-MYERS SQUIBB COMPANY (DEMONSTRate: Drug Evalutation in Melanoma: ONcology STudy and Research of Ipilimumab)

Burza cenných papírů: Více informací o BRISTOL-MYERS SQUIBB COMPANY (DEMONSTRate: Drug Evalutation in Melanoma: ONcology STudy and Research of Ipilimumab)

DEMONSTRate: Drug Evalutation in Melanoma: ONcology STudy and Research of Ipilimumab je značkou BRISTOL-MYERS SQUIBB COMPANY (BMY). Novinky

Všechny novinky BRISTOL-MYERS SQUIBB COMPANY (DEMONSTRate: Drug Evalutation in Melanoma: ONcology STudy and Research of Ipilimumab)

Všechny novinky
BRISTOL-MYERS SQUIBB COMPANY (DEMONSTRate: Drug Evalutation in Melanoma: ONcology STudy and Research of Ipilimumab)